Results 1-20 of 70 for drugs speaker:Pádraig O'Sullivan

Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021: Second Stage [Private Members] (3 Dec 2021)

Pádraig O'Sullivan: ...our own Deputy Lahart are on the Committee on Health. They are passionate about this topic. I will make a couple of comments in summary. There are a few inescapable truths. One is that these drugs are expensive. Of that, there is no doubt. The second inescapable truth is that we as a country make people wait much longer than they probably should, certainly compared to our European...

Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021: Second Stage [Private Members] (3 Dec 2021)

Pádraig O'Sullivan: ...the good work of the Minister for Health, Deputy Stephen Donnelly. I am aware that he has to go to a Cabinet sub-committee meeting now, but since he has assumed office he has provided the largest drugs budget in the history of the State, adding €50 million to the overall budget this year. This investment needs to be acknowledged as it eclipses any previous drugs budget the State...

Joint Oireachtas Committee on Health: Rare Diseases: Discussion (Resumed) (22 Jun 2022)

Pádraig O'Sullivan: ...waiting times ranging from 800 to 1,200 days, depending on criteria. Is that reflective of a sustainable reimbursement system? In Ireland we do not have a specific pathway to assess orphan drugs and it is part of the mainstream assessment. In Belgium is there a specific assessment pathway for orphan drugs, or is it like the Irish system, where every drug is assessed under the same...

Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021: First Stage (5 Oct 2021)

Pádraig O'Sullivan: ..., in essence, is a reintroduction of the work he undertook a few years ago. I also acknowledge that the Minister for Health is here today and that he made an extra €50 million available in the drugs budget in the last year, which is also to be commended. Under the existing legislation, there is no differentiation between orphan medicinal products and other products in Ireland....

Ceisteanna - Questions: Cabinet Committees (28 Mar 2023)

Pádraig O'Sullivan: ...work of late by publishing the Mazars report and commencing the successor to the National Rare Disease Plan. Of course, we have invested more than €100 million in the last three years in orphan drugs. Last Thursday, I raised this issue again with the Tánaiste and gave the example of Luxturna, which has now been before the drugs group for assessment for reimbursement for 1,280...

Rare Diseases: Statements (6 Mar 2024)

Pádraig O'Sullivan: ...rapid access to medicines. It has been noted in various medical journals published across Europe that Ireland is consistently at the tail end in a European context when it comes to the approval of drugs. I hate to focus all my time on drugs, but we are looking at delays here of up to 1,100 days, depending on the drug and on the process that it has gone through. I said to the Minister at...

Estimates for Public Services 2023: Programme for Government (5 Dec 2023)

Pádraig O'Sullivan: I raise again the issue of rare diseases. While I welcome much of the progress we have achieved in the past two years in government, particularly with the number of drugs to which people have access - more than 80 at this stage, which is great progress - I still feel somewhat disappointed that next year's budget did not contain a stand-alone budget for new drugs for rare diseases. I know...

Written Answers — Department of Health: Medicinal Products (9 Mar 2023)

Pádraig O'Sullivan: 320. To ask the Minister for Health the number of EMA-approved orphan drugs that were approved for reimbursement in each of the years 2016 to 2022; the date these drugs were applied for initially, in tabular form; and if he will make a statement on the matter. [12035/23]

Written Answers — Department of Health: Medicinal Products (8 May 2024)

Pádraig O'Sullivan: 619. To ask the Minister for Health the reimbursement status of the drug ravulizumab for paroxysmal nocturnal haemoglobinuria and atypical haemolytic uremic syndrome; when he expects this drug to be made available; and if he will make a statement on the matter. [20786/24]

Written Answers — Department of Justice and Equality: An Garda Síochána (21 Oct 2021)

Pádraig O'Sullivan: 142. To ask the Tánaiste and Minister for Justice and Equality if her attention has been drawn to the fact that drug offences in Cork are rising; the drug squad numbers in the Cork division in each the years 2019, 2020 and to date in 2021; and if she will make a statement on the matter. [51549/21]

Saincheisteanna Tráthúla - Topical Issue Debate: Medicinal Products (31 Mar 2022)

Pádraig O'Sullivan: ...his responsibility or area of expertise but there are some things I have an issue with in the response. One is that the HSE has approved 52 new medicines, including Zolgensma. Many of these new drugs were approved through the Benelux arrangement the Minister of State referenced in his response. He went on to say about 97 new medicinal indications including treatments for rare diseases...

Saincheisteanna Tráthúla - Topical Issue Debate: Medicinal Products (26 May 2022)

Pádraig O'Sullivan: I thank the Minister of State, Deputy Rabbitte, who has been here on more than a few occasions to answer questions in regard to rare diseases and orphan drugs, and now this issue pertaining to the establishment of the medicines agency. As the Minister of State is aware, this is a commitment in the programme for Government. We are over two years into government and while I can probably guess...

Written Answers — Department of Health: Medicinal Products (17 Jan 2024)

Pádraig O'Sullivan: 1513. To ask the Minister for Health if the additional €92 million allocated to health as part of the revised estimates volume will include funding for new drugs in 2024; how much of that funding will be allocated to new drugs; if he will provide further information and clarity on the matter; and if he will make a statement on the matter. [56612/23]

Ceisteanna - Questions: Cabinet Committees (5 Mar 2024)

Pádraig O'Sullivan: .... We have spoken about it before and I welcome its publication, but the reality is that the report will not meaningfully reduce the times for which people are waiting for the approval of an orphan drug. When this Government took office, there was an average of more than 900 days for a drug to be approved through the HTA process. When this Government finishes office, which will be any...

Written Answers — Department of Health: Medicinal Products (29 Feb 2024)

Pádraig O'Sullivan: 26. To ask the Minister for Health if he will supply data for the ten fastest and ten slowest approvals of orphan drugs by the HSE, by year, for the period 2014 to 2023, stating the date on which the applications for said drugs were received by the HSE and the date on which a reimbursement decision was subsequently made, in tabular form; and if he will make a statement on the matter. [9461/24]

Written Answers — Department of Health: Medicinal Products (5 Mar 2024)

Pádraig O'Sullivan: 706. To ask the Minister for Health if he will supply data, in tabular form, for the ten fastest, and ten slowest approvals of orphan drugs by the HSE, by year (for the period 2014 to 2023), stating the date on which the applications for said drugs were received by the HSE and the data on which a reimbursement decision was subsequently made; and if he will make a statement on the matter....

Ceisteanna ar Reachtaíocht a Gealladh - Questions on Promised Legislation (7 Apr 2022)

Pádraig O'Sullivan: I am glad the Tánaiste is present. Given that he is a former Minister for Health, he may be able to provide some insight on the ongoing difficulties about rare diseases and orphan drugs, and, in particular, the commitment in the programme for Government for a successor to the national rare disease plan. In addition, I am also interested in the publication - this has not yet happened...

An tOrd Gnó (Atógáil) - Order of Business (Resumed) (17 Oct 2023)

Pádraig O'Sullivan: ...in recent weeks. However, I feel this is an issue that warrants raising again. I raised with the Taoiseach earlier this year that there was an underspend for 2022, particularly in the area of new drugs. I received a response to a parliamentary question to the effect that approximately €10 million was drawn down of the €30 million allocated for 2022. I am concerned that...

Ceisteanna ar Pholasaí nó ar Reachtaíocht - Questions on Policy or Legislation (27 Oct 2022)

Pádraig O'Sullivan: I have previously raised the issue of drug reimbursement in this country with the Tánaiste and the Taoiseach and last week, the Swedish Institute for Health Economics published a report on cancer outcomes in Ireland. It found that while much progress was made, we are still among the worst in the EU for ovarian and breast cancer outcomes. The report specifically cited that our drug...

An tOrd Gnó - Order of Business (6 Jul 2021)

Pádraig O'Sullivan: I would like to raise the issue of rare diseases and orphan drugs. This is an issue which the Taoiseach would have a lot of experience of, having served as Minister for Health and given his engagement with the Orkambi case. Today, Senator Malcolm Byrne, Senator Fiona O'Loughlin and I launched our Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021, which is essentially a...